The Cooper Companies, Inc. $COO Shares Acquired by Inlet Private Wealth LLC

Inlet Private Wealth LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 571.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,920 shares of the medical device company’s stock after buying an additional 33,120 shares during the period. Inlet Private Wealth LLC’s holdings in Cooper Companies were worth $2,200,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in Cooper Companies in the 2nd quarter valued at about $1,077,762,000. Generation Investment Management LLP purchased a new stake in shares of Cooper Companies during the second quarter worth about $356,304,000. Jupiter Topco LLC purchased a new stake in shares of Cooper Companies during the second quarter worth about $305,074,000. Bank of America Corp DE purchased a new stake in shares of Cooper Companies during the second quarter worth about $144,125,000. Finally, Manning & Napier Advisors LLC acquired a new position in shares of Cooper Companies in the second quarter worth about $107,939,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on COO shares. Weiss Ratings raised Cooper Companies from a “sell (d)” rating to a “hold (c-)” rating in a report on Friday, September 18th. Bank of America reiterated a “neutral” rating and set a $65.00 target price (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Mizuho set a $75.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, September 10th. Needham & Company LLC decreased their price target on shares of Cooper Companies from $86.00 to $73.00 and set a “buy” rating for the company in a research report on Thursday, September 10th. Finally, Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, September 12th. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Hold” and a consensus target price of $68.60.

Insider Activity

In other news, Director Walter M. Rosebrough, Jr. acquired 3,000 shares of Cooper Companies stock in a transaction that occurred on Monday, September 14th. The shares were purchased at an average cost of $54.29 per share, for a total transaction of $162,870.00. Following the completion of the purchase, the director directly owned 20,000 shares of the company’s stock, valued at $1,085,800. This trade represents a 17.65% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Lawrence Kurzius acquired 10,000 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 16th. The shares were purchased at an average price of $54.93 per share, for a total transaction of $549,300.00. Following the completion of the purchase, the director directly owned 31,099 shares of the company’s stock, valued at $1,708,268.07. The trade was a 47.40% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders bought 34,701 shares of company stock worth $1,880,039. 2.08% of the stock is currently owned by insiders.

Cooper Companies Stock Down 0.3%

NASDAQ:COO opened at $58.97 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The company has a market capitalization of $11.21 billion, a price-to-earnings ratio of 20.13, a price-to-earnings-growth ratio of 2.41 and a beta of 0.83. The Cooper Companies, Inc. has a one year low of $51.01 and a one year high of $89.83. The stock has a 50-day simple moving average of $62.38 and a 200 day simple moving average of $65.86.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter last year, the business posted $0.49 EPS. Cooper Companies’s quarterly revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies announced that its board has authorized a stock repurchase plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in outstanding shares. This buyback authorization allows the medical device company to buy up to 22.7% of its shares through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

Cooper Companies Company Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women’s health.